News

Born with congenital heart disease, 41-year-old Christin Murphy has undergone three heart surgeries to repair pulmonary valves. They have been tough to get through, but Murphy says this latest one at Saint Luke’s changed her outlook.

While chemotherapy, radiation, and surgeries are common for most cancer treatments, immunotherapy is continuing to allow some patients to forgo these often harsh and invasive methods altogether.

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.

More than 10 years after his diagnosis, he’s helping other people with the same rare cancer to hold on to hope.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

TAVR in asymptomatic and minimally symptomatic patients is associated with a high survival rate, but relatively minor improvements, according to new research.

Local anchor, Christel Bell, came to Saint Luke's Hospital of Kansas City when she knew something wasn't right.

The Koontz Center has cared for hundreds of patients with Stage 4 metastatic breast cancer since its inception in 2016.

Rehospitalization after aortic valve replacement (AVR) is associated with an increased risk of patient mortality, according to new research.

When Dale Cooksey's mitral valve wasn't sealing normally, doctors at Saint Luke's Mid America Heart Institute performed the MitraClip procedure to get the 98-year-old back to his active lifestyle quickly.